8
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Successful treatment of cutaneous sporotrichosis with terbinafine

, , , &
Pages 33-35 | Received 17 Jun 1995, Accepted 08 Sep 1995, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dh Ellis. (1998) The potential for terbinafine in non-dermatophyte fungal infections with or without skin involvement. Journal of Dermatological Treatment 9:sup1, pages S35-S38.
Read now

Articles from other publishers (6)

Peter G. Pappas. 2011. Essentials of Clinical Mycology. Essentials of Clinical Mycology 113 119 .
Malcolm D Richardson, Caroline B Moore, Richard C Summerbell & Aditya K Gupta. 2010. Infectious Diseases. Infectious Diseases 1853 1867 .
S. W. Chapman, P. Pappas, C. Kauffmann, E. B. Smith, R. Dietze, N. Tiraboschi-Foss, A. Restrepo, A. B. Bustamante, C. Opper, S. Emady-Azar & R. Bakshi. (2004) Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day-1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Vergleichende Bewertung der Wirksamkeit und Sicherheit zweier Terbinafin-Dosierungen (500 und 1000 mg/Tag) in der Therapie der kutanen und lymphokutanen Sporotrichose. Mycoses 47:1-2, pages 62-68.
Crossref
H. Tanuma, T. Asai, M. Abe, S. Nishiyama & K. Katsuoka. (2001) Case Report. Lymphatic vessel-type sporotrichosis: immunohistochemical evaluation and cytokine expression pattern. Mycoses 44:7-8, pages 316-320.
Crossref
H. Tanuma, T. Asai, M. Abe, S. Nishiyama & K. Katsuoka. (2001) Case Report. Lymphatic vessel-type sporotrichosis: immunohistochemical evaluation and cytokine expression pattern. Mycoses 44:7-8, pages 316-320.
Crossref
Hay. (1999) Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. British Journal of Dermatology 141:s56, pages 36-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.